SMi Systems
Home Our Technology Biomedical Research Diagnosis Team Investors News Publications Careers Contact
HomeOur TechnologyBiomedical Research DiagnosisTeamInvestorsNewsPublicationsCareersContact
SMi Systems
SMi Systems awarded second R&D contract from top 20 biopharma company

SMi has been contracted to develop another Quality Control assay that enables single molecule detection of contaminating infectious particles. .

 

VIEW PDF
Lucy Eccleston29 January 20252025
Facebook0 Twitter 0 Likes
Previous

SMi summarises the potential for single molecule imaging in Ab discovery and vaccine development

Lucy Eccleston11 March 2025Home News Block, 2025
Next

SMi Systems secures US patent allowance

Lucy Eccleston7 January 20252025
 

About Us
About SMi
Meet the Team
Careers
Investors
Publications
News
Contact Us

Technology & Sectors
Our Technology
Biomedical Research
Diagnosis

 

Policies & Information
Privacy Policy
Terms of Use
Company Information
Recruitment Privacy Policy

SMi Drug Discovery
Company Registration No.: 11175710
VAT No.: 332498687
Trading as SMi Systems

© 2024 SMi Drug Discovery Limited